Tarrytown, N.Y.-based Regeneron Pharmaceuticals said the FDA declined to approve its blood cancer therapy for two forms of lymphoma over concerns about the ongoing confirmatory trials.
The Latest
Tom Purcell, MD, started his career in business consulting, and it was not until he was 28 that he first entered medical school.
Castle Connolly's 2024 accolades honored 13 hospitals and systems for having the most top-rated cancer care physicians.
The Indiana University Melvin and Bren Simon Comprehensive Cancer Center has received a $20 million gift to put toward the development of a new research center for lung cancer.
Clinical trials are top of mind for Abhisek Swaika, MD, including how to improve access and build an infrastructure of care that patients seek, especially in the community setting.
Forty comprehensive cancer centers have committed to using new billing codes to provide navigation services for cancer patients as part of the Biden administration's Cancer Moonshot.
Breast cancer diagnoses dropped 15.7% for women and 21.8% for men during the pandemic, according to a study involving nearly 1.5 million patients.
Three Chicago health systems have collaborated with a nonprofit foundation to launch the Chicago Breast Cancer Research Consortium.
It was a feeling of helplessness that led Mark Evers, MD, a gastrointestinal surgeon, to pursue cancer research.
Patients with metabolic syndrome have an increased risk for developing various types of cancer, according to new research from Gateway for Cancer Research, a nonprofit group based in Schaumburg, Ill.